Journal of General Internal Medicine

, Volume 22, Issue 11, pp 1560–1565 | Cite as

Geographic Variation in Chronic Obstructive Pulmonary Disease Exacerbation Rates

Original Article

Abstract

Background

Exacerbations are important disease events for patients with chronic obstructive pulmonary disease (COPD) as they are relatively frequent, result in significant resource use and can indicate worsening disease. Little is known about variation in COPD exacerbation rates across a health system in various geographic regions.

Objective

To compare COPD exacerbation rates by regional service networks called Veterans Integrated Service Network (VISN) in the Veterans Health Administration (VA) system.

Design

Retrospective, observational study.

Subjects

Patients with a COPD diagnosis from October 1999 to September 2000 with follow-up to September 2002.

Measurements

Acute exacerbations of COPD during the baseline and follow-up periods.

Results

A total of 198,981 patients were identified. Average exacerbation rate at baseline was 0.503 events per person per year. In the follow-up period, there were 187,686 exacerbations experienced by 87,494 persons (44.0% of cohort). During follow-up, the average adjusted exacerbation rate was 0.589 per person per year and varied from 0.335 (95% CI, 0.328–0.342) in VISN 1 to 0.749 (95% CI, 0.735–0.0.763) in VISN 9. Using the median rate of exacerbation during the baseline period as the referent, 9 VISNs had lower adjusted rate ratios and 12 VISNs had higher adjusted rate ratios in the follow-up period.

Conclusions

Geographic variation in the VA VISN system supports evidence that the medical care system including provider factors, and less so patient factors, affect COPD exacerbations. Understanding the reasons underlying this variation in COPD exacerbation rates may lead to improvements in future care and outcomes.

KEY WORDS

COPD exacerbation geographic variation outcomes 

Notes

Acknowledgments

This research was supported in part by VA HSR&D IIR 03-307 and an unrestricted research grant from Astra-Zeneca Pharmaceuticals. Dr. Joo received support from a T32 (5T32HS000078-08) training grant while conducting this research. The funding agencies had no role in the design, conduct, or interpretation of the study results. A portion of this work was presented at the American Thoracic Society meeting in San Diego, CA, May 2005, in abstract form. Dr. Lee has received research grants from Astra-Zeneca, Pfizer, and Boehringer-Ingelheim in the past 3 years. Disclaimer: The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the United States Government.

Conflict of Interest

None disclosed.

References

  1. 1.
    Hilleman DE, Dewan N, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest. 2000;118:1278–85.CrossRefPubMedGoogle Scholar
  2. 2.
    Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000;117:5S–9S.CrossRefPubMedGoogle Scholar
  3. 3.
    Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–52.CrossRefPubMedGoogle Scholar
  4. 4.
    Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001;164:358–64.PubMedGoogle Scholar
  5. 5.
    Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med. 2007;101:1305–12.CrossRefPubMedGoogle Scholar
  6. 6.
    Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59:387–95.CrossRefPubMedGoogle Scholar
  7. 7.
    Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004;23:698–702.CrossRefPubMedGoogle Scholar
  8. 8.
    Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418–22.PubMedGoogle Scholar
  9. 9.
    Osman IM, Godden DJ, Friend JA, Legge JS, Douglas JG. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax. 1997;52:67–71.PubMedCrossRefGoogle Scholar
  10. 10.
    Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006;129:1509–15.CrossRefPubMedGoogle Scholar
  11. 11.
    Ashton CM, Petersen NJ, Souchek J, et al. Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. N Engl J Med. 1999;340:32–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144:894–903.PubMedGoogle Scholar
  13. 13.
    Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003;41:46s–53s.CrossRefPubMedGoogle Scholar
  14. 14.
    Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608–13.PubMedGoogle Scholar
  15. 15.
    The United States Department of Commerce. Climatography of the United States Report No. 85 (Divisional Normals and Standard Deviations of Temperature, Precipitation, and Heating and Cooling Degree Days, 1971–2000); 2003.Google Scholar
  16. 16.
    Byers AL, Allore H, Gill TM, Peduzzi PN. Application of negative binomial modeling for discrete outcomes: a case study in aging research. J Clin Epidemiol. 2003;56:559–64.CrossRefPubMedGoogle Scholar
  17. 17.
    Gardner W, Mulvey EP, Shaw EC. Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. Psychol Bull. 1995;118:392–404.CrossRefPubMedGoogle Scholar
  18. 18.
    Slymen DJ, Ayala GX, Arredondo EM, Elder JP. A demonstration of modeling count data with an application to physical activity. Epidemiol Perspect Innov. 2006;3:3.CrossRefPubMedGoogle Scholar
  19. 19.
    Veterans Health Administration. Available at: http://www1.va.gov/directory/guide/division_flsh.asp?dnum=1. Accessed April 30, 2007.
  20. 20.
    Menon V, Rumsfeld JS, Roe MT, et al. Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromes. Am J Med. 2006;119:584–90.CrossRefPubMedGoogle Scholar
  21. 21.
    Krumholz HM, Chen J, Rathore SS, Wang Y, Radford MJ. Regional variation in the treatment and outcomes of myocardial infarction: investigating New England’s advantage. Am Heart J. 2003;146:242–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Subramanian U, Weinberger M, Eckert GJ, L’Italien GJ, Lapuerta P, Tierney W. Geographic variation in health care utilization and outcomes in veterans with acute myocardial infarction. J Gen Intern Med. 2002;17:604–11.CrossRefPubMedGoogle Scholar
  23. 23.
    Lougheed MD, Garvey N, Chapman KR, et al. The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest. 2006;129:909–17.CrossRefPubMedGoogle Scholar
  24. 24.
    Weinstein JN, Bronner KK, Morgan TS, Wennberg JE. Trends and geographic variations in major surgery for degenerative diseases of the hip, knee, and spine. Health Aff (Millwood). 2004;Suppl Web Exclusive:VAR81-9.Google Scholar
  25. 25.
    Doherty MJ, Greenstone MA. Survey of non-invasive ventilation (NIPPV) in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) in the UK. Thorax. 1998;53:863–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Kinnunen T, Saynajakangs O, Tuuponen T, Keistinen T. Regional and seasonal variation in the length of hospital stay for chronic obstructive pulmonary disease in Finland. Int J Circumpolar Health. 2002;61:131–5.PubMedGoogle Scholar
  27. 27.
    Maheshwari V, Paioli D, Rothaar R, Hill NS. Utilization of noninvasive ventilation in acute care hospitals: a regional survey. Chest. 2006;129:1226–33.CrossRefPubMedGoogle Scholar
  28. 28.
    Ringbaek TJ, Lange P, Viskum K. Geographic variation in long-term oxygen therapy in Denmark: factors related to adherence to guidelines for long-term oxygen therapy. Chest. 2001;119:1711–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Helmer DA, Tseng CL, Brimacombe M, Rajan M, Stiptzarov N, Pogach L. Applying diabetes-related prevention quality indicators to a national cohort of veterans with diabetes. Diabetes Care. 2003;26:3017–23.CrossRefPubMedGoogle Scholar
  30. 30.
    Murdoch M, Hodges J, Cowper D, Sayer N. Regional variation and other correlates of Department of Veterans Affairs Disability Awards for patients with posttraumatic stress disorder. Med Care. 2005;43:112–21.CrossRefPubMedGoogle Scholar
  31. 31.
    Tseng CL, Greenberg JD, Helmer D, et al. Dual-system utilization affects regional variation in prevention quality indicators: the case of amputations among veterans with diabetes. Am J Manag Care. 2004;10:886–92.PubMedGoogle Scholar
  32. 32.
    Wilt TJ, Cowper DC, Gammack JK, Going DR, Nugent S, Borowsky SJ. An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes. Med Care. 1999;37:1046–56.CrossRefPubMedGoogle Scholar
  33. 33.
    Jones PW, Willits LR, Burge PS, Calverley PM. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J. 2003;21:68–73.CrossRefPubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 2007

Authors and Affiliations

  • Min J. Joo
    • 1
    • 2
    • 4
  • Todd A. Lee
    • 1
    • 2
    • 3
  • Kevin B. Weiss
    • 1
    • 2
    • 3
  1. 1.Center for Management of Complex Chronic CareHines VA HospitalHinesUSA
  2. 2.Institute for Healthcare StudiesNorthwestern University Feinberg School of MedicineChicagoUSA
  3. 3.Division of General Internal Medicine, Department of MedicineNorthwestern University Feinberg School of MedicineChicagoUSA
  4. 4.University of IllinoisChicagoUSA

Personalised recommendations